Wake Forest researchers have reprogrammed macrophages to target metastatic tumors in the brain, offering a potential new approach where conventional therapies struggle.
AI and high-throughput functional screening helped researchers design antibodies that selectively activate CB2, reducing inflammation and scar tissue in human liver tissue.
By adopting Simplicis Ledger, Flare Therapeutics replaces manual "human-babysitting" of data with automation-ready infrastructure to scale life sciences R&D.
A first UK birth from a deceased-donor womb transplant, a billion-dollar siRNA deal for GSK, a sobering setback for early cancer blood tests, and more led the news this week.
In this two-day symposium, explore the scientific and practical advances shaping how cell and gene therapies are developed, delivered, and brought to patients.